A phase II study of M605106 for acne vulgaris
Phase 2
- Conditions
- Acne vulgaris
- Registration Number
- JPRN-jRCT2031210011
- Lead Sponsor
- ishiura Tomoyuki
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 240
Inclusion Criteria
Patients with Acne vulgaris 12 to 49 years old
Exclusion Criteria
- Patients with concurrent presense of serious cardiac, hepatic, renal, plumonary, hematologic, or other diseases considered inappropriate for paticipation in the clinical study
- Patients with a history of hypersensitivity to investigational drug ingredients
- Pregnant or lactating women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage change in total lesion count after a certain period
- Secondary Outcome Measures
Name Time Method